| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |